MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Explore the impact of genetic testing on diagnosing Dilated Cardiomyopathy 1KK, unveiling genetic variants for personalized treatment and family risk assessment.
Explore how genetic testing aids in diagnosing and managing Distal Arthrogryposis Type 5D, a rare disorder linked to ECEL1 gene mutations, improving patient care.
Explore Dowling-Degos Disease 2, a rare skin disorder. Learn how genetic testing aids in diagnosis, personalized treatment, and genetic counseling for affected families.
Explore the impact of genetic testing in diagnosing Dyschromatosis Universalis Hereditaria 3, understanding hereditary patterns, and guiding effective management strategies.
Explore the role of genetic testing in diagnosing Dyskeratosis Congenita Autosomal Recessive 5, offering insights for personalized treatment and family planning.
Uncover how genetic testing aids Dystonia 24 diagnosis, guides treatment, predicts progression, and supports family planning, enhancing patient care profoundly.
Genetic testing enhances Dystonia 25 diagnosis and treatment, offering precise identification of genetic mutations for personalized therapies and informed family planning.
Unlock the potential of genetic testing in diagnosing and managing Ehlers-Danlos syndrome, spondylodysplastic type, with new insights on the THBS2 mutation.